Global (United States, European Union and China) Diagnostic Reagents

Diagnostic Reagents Comprehensive Study by Type (Reagents & Kits, Instruments, Others), Application (Infectious Diseases (HIV, HAIs, HPV, TB), Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer), Genetic Tests, Other), Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Others), End-Users (Hospitals & Clinics, Research Laboratories, Academic Laboratories, Others) Players and Region - Global Market Outlook to 2028

Diagnostic Reagents Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Diagnostic Reagents
Diagnostic reagents are a medical device that is that includes reagents, calibrators, instruments, and systems used in the diagnosis of a disease or other conditions, including a determination of the state of health, in order to prevent disease. Such products can be used independently or can used in combination with other instruments, facilities or systems. Diagnostic reagents play the main role in medical labs, as they help to produce test results through diagnostic testing assays. Diagnostic reagents can be used to generate accurate and precise patient test results whether they are chemical, or biochemical in design.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Diagnostic Reagents market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Lifecycle Biotechnologies (United States), Pointe Scientific, Inc. (United States), Abbott Laboratories (United States), Agilent Technologies (United States), Becton, Dickinson and Company (United States), Danaher Corporation (United States), Hologic (United States), Illumina (United States), Qiagen (Germany), Roche Diagnostics (Switzerland), Siemens AG (Germany), Thermo Fisher Scientific (United States) and BioMerieux (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Diasorin (Italy) and Grifols (Spain).

Segmentation Overview
AMA Research has segmented the market of Global Diagnostic Reagents market by Type (Reagents & Kits, Instruments and Others), Application (Infectious Diseases [HIV, HAIs, HPV, TB], Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer], Genetic Tests and Other) and Region.



On the basis of geography, the market of Diagnostic Reagents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Polymerase Chain Reaction (PCR) will boost the Diagnostic Reagents market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-Users, the sub-segment i.e. Hospitals & Clinics will boost the Diagnostic Reagents market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advancements in Molecular Techniques

Market Growth Drivers:
Increasing Incidence of Infectious Diseases and Various Types of Cancers and Rising Acceptance of Personalized Medicine and Companion Diagnostics

Challenges:
Shortage of Trained Professionals for Use of New Molecular Diagnostic Technologies

Restraints:
Complex Regulatory Frameworks and Delay in the Approval of New Molecular Diagnostic Tests

Opportunities:
Developments in Genomics and Proteomics

Market Leaders and their expansionary development strategies
On September 16, 2019 - Abbott and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with Sanofi′s insulin dosing information for future smart pens, insulin titration apps, and cloud software. and On March 19, 2019 - Baxter International Inc., a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, has announced an agreement to develop future biomarkers with the goal to rapidly identify and inform the treatment of acute kidney injury (AKI).
In March 2022, Healthcare company Mylab Discovery Solutions has announced its plans to launch an entire range of routine diagnostic kits and devices in conventional and POCT format. It will include the devices and kits for three major sub-segments of the market immunology, biochemistry and haematology.


Key Target Audience
Manufacturers of Diagnostic Reagents, Wholesalers, Distributors and Retailers of Diagnostic Reagents, Healthcare Industry, Research Institutes, Reference Laboratories and Diagnostics Suppliers

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Reagents & Kits
  • Instruments
  • Others
By Application
  • Infectious Diseases [HIV, HAIs, HPV, TB]
  • Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer]
  • Genetic Tests
  • Other
By Technology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Others

By End-Users
  • Hospitals & Clinics
  • Research Laboratories
  • Academic Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Infectious Diseases and Various Types of Cancers
      • 3.2.2. Rising Acceptance of Personalized Medicine and Companion Diagnostics
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Trained Professionals for Use of New Molecular Diagnostic Technologies
    • 3.4. Market Trends
      • 3.4.1. Advancements in Molecular Techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostic Reagents, by Type, Application, Technology, End-Users and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Diagnostic Reagents (Value)
      • 5.2.1. Global Diagnostic Reagents by: Type (Value)
        • 5.2.1.1. Reagents & Kits
        • 5.2.1.2. Instruments
        • 5.2.1.3. Others
      • 5.2.2. Global Diagnostic Reagents by: Application (Value)
        • 5.2.2.1. Infectious Diseases [HIV, HAIs, HPV, TB]
        • 5.2.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer]
        • 5.2.2.3. Genetic Tests
        • 5.2.2.4. Other
      • 5.2.3. Global Diagnostic Reagents by: Technology (Value)
        • 5.2.3.1. Polymerase Chain Reaction (PCR)
        • 5.2.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 5.2.3.3. DNA Sequencing & Next-Generation Sequencing (NGS)
        • 5.2.3.4. DNA Microarray
        • 5.2.3.5. Others
      • 5.2.4. Global Diagnostic Reagents by: End-Users (Value)
        • 5.2.4.1. Hospitals & Clinics
        • 5.2.4.2. Research Laboratories
        • 5.2.4.3. Academic Laboratories
        • 5.2.4.4. Others
      • 5.2.5. Global Diagnostic Reagents Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Diagnostic Reagents (Volume)
      • 5.3.1. Global Diagnostic Reagents by: Type (Volume)
        • 5.3.1.1. Reagents & Kits
        • 5.3.1.2. Instruments
        • 5.3.1.3. Others
      • 5.3.2. Global Diagnostic Reagents by: Application (Volume)
        • 5.3.2.1. Infectious Diseases [HIV, HAIs, HPV, TB]
        • 5.3.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer]
        • 5.3.2.3. Genetic Tests
        • 5.3.2.4. Other
      • 5.3.3. Global Diagnostic Reagents by: Technology (Volume)
        • 5.3.3.1. Polymerase Chain Reaction (PCR)
        • 5.3.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 5.3.3.3. DNA Sequencing & Next-Generation Sequencing (NGS)
        • 5.3.3.4. DNA Microarray
        • 5.3.3.5. Others
      • 5.3.4. Global Diagnostic Reagents by: End-Users (Volume)
        • 5.3.4.1. Hospitals & Clinics
        • 5.3.4.2. Research Laboratories
        • 5.3.4.3. Academic Laboratories
        • 5.3.4.4. Others
      • 5.3.5. Global Diagnostic Reagents Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Diagnostic Reagents (Price)
      • 5.4.1. Global Diagnostic Reagents by: Type (Price)
  • 6. Diagnostic Reagents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Lifecycle Biotechnologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pointe Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agilent Technologies (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton, Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Illumina (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Qiagen (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Roche Diagnostics (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Siemens AG (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Thermo Fisher Scientific (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. BioMerieux (France)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Diagnostic Reagents Sale, by Type, Application, Technology, End-Users and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Diagnostic Reagents (Value)
      • 7.2.1. Global Diagnostic Reagents by: Type (Value)
        • 7.2.1.1. Reagents & Kits
        • 7.2.1.2. Instruments
        • 7.2.1.3. Others
      • 7.2.2. Global Diagnostic Reagents by: Application (Value)
        • 7.2.2.1. Infectious Diseases [HIV, HAIs, HPV, TB]
        • 7.2.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer]
        • 7.2.2.3. Genetic Tests
        • 7.2.2.4. Other
      • 7.2.3. Global Diagnostic Reagents by: Technology (Value)
        • 7.2.3.1. Polymerase Chain Reaction (PCR)
        • 7.2.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 7.2.3.3. DNA Sequencing & Next-Generation Sequencing (NGS)
        • 7.2.3.4. DNA Microarray
        • 7.2.3.5. Others
      • 7.2.4. Global Diagnostic Reagents by: End-Users (Value)
        • 7.2.4.1. Hospitals & Clinics
        • 7.2.4.2. Research Laboratories
        • 7.2.4.3. Academic Laboratories
        • 7.2.4.4. Others
      • 7.2.5. Global Diagnostic Reagents Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Diagnostic Reagents (Volume)
      • 7.3.1. Global Diagnostic Reagents by: Type (Volume)
        • 7.3.1.1. Reagents & Kits
        • 7.3.1.2. Instruments
        • 7.3.1.3. Others
      • 7.3.2. Global Diagnostic Reagents by: Application (Volume)
        • 7.3.2.1. Infectious Diseases [HIV, HAIs, HPV, TB]
        • 7.3.2.2. Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer]
        • 7.3.2.3. Genetic Tests
        • 7.3.2.4. Other
      • 7.3.3. Global Diagnostic Reagents by: Technology (Volume)
        • 7.3.3.1. Polymerase Chain Reaction (PCR)
        • 7.3.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
        • 7.3.3.3. DNA Sequencing & Next-Generation Sequencing (NGS)
        • 7.3.3.4. DNA Microarray
        • 7.3.3.5. Others
      • 7.3.4. Global Diagnostic Reagents by: End-Users (Volume)
        • 7.3.4.1. Hospitals & Clinics
        • 7.3.4.2. Research Laboratories
        • 7.3.4.3. Academic Laboratories
        • 7.3.4.4. Others
      • 7.3.5. Global Diagnostic Reagents Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Diagnostic Reagents (Price)
      • 7.4.1. Global Diagnostic Reagents by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostic Reagents: by Type(USD Million)
  • Table 2. Diagnostic Reagents Reagents & Kits , by Region USD Million (2017-2022)
  • Table 3. Diagnostic Reagents Instruments , by Region USD Million (2017-2022)
  • Table 4. Diagnostic Reagents Others , by Region USD Million (2017-2022)
  • Table 5. Diagnostic Reagents: by Application(USD Million)
  • Table 6. Diagnostic Reagents Infectious Diseases [HIV, HAIs, HPV, TB] , by Region USD Million (2017-2022)
  • Table 7. Diagnostic Reagents Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer] , by Region USD Million (2017-2022)
  • Table 8. Diagnostic Reagents Genetic Tests , by Region USD Million (2017-2022)
  • Table 9. Diagnostic Reagents Other , by Region USD Million (2017-2022)
  • Table 10. Diagnostic Reagents: by Technology(USD Million)
  • Table 11. Diagnostic Reagents Polymerase Chain Reaction (PCR) , by Region USD Million (2017-2022)
  • Table 12. Diagnostic Reagents Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region USD Million (2017-2022)
  • Table 13. Diagnostic Reagents DNA Sequencing & Next-Generation Sequencing (NGS) , by Region USD Million (2017-2022)
  • Table 14. Diagnostic Reagents DNA Microarray , by Region USD Million (2017-2022)
  • Table 15. Diagnostic Reagents Others , by Region USD Million (2017-2022)
  • Table 16. Diagnostic Reagents: by End-Users(USD Million)
  • Table 17. Diagnostic Reagents Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 18. Diagnostic Reagents Research Laboratories , by Region USD Million (2017-2022)
  • Table 19. Diagnostic Reagents Academic Laboratories , by Region USD Million (2017-2022)
  • Table 20. Diagnostic Reagents Others , by Region USD Million (2017-2022)
  • Table 21. South America Diagnostic Reagents, by Country USD Million (2017-2022)
  • Table 22. South America Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 23. South America Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 24. South America Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 25. South America Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 26. Brazil Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 27. Brazil Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 28. Brazil Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 29. Brazil Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 30. Argentina Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 31. Argentina Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 32. Argentina Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 33. Argentina Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 34. Rest of South America Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 35. Rest of South America Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 36. Rest of South America Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 37. Rest of South America Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 38. Asia Pacific Diagnostic Reagents, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 40. Asia Pacific Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 41. Asia Pacific Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 42. Asia Pacific Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 43. China Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 44. China Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 45. China Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 46. China Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 47. Japan Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 48. Japan Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 49. Japan Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 50. Japan Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 51. India Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 52. India Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 53. India Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 54. India Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 55. South Korea Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 56. South Korea Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 57. South Korea Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 58. South Korea Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 59. Taiwan Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 60. Taiwan Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 61. Taiwan Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 62. Taiwan Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 63. Australia Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 64. Australia Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 65. Australia Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 66. Australia Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 71. Europe Diagnostic Reagents, by Country USD Million (2017-2022)
  • Table 72. Europe Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 73. Europe Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 74. Europe Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 75. Europe Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 76. Germany Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 77. Germany Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 78. Germany Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 79. Germany Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 80. France Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 81. France Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 82. France Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 83. France Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 84. Italy Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 85. Italy Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 86. Italy Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 87. Italy Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 88. United Kingdom Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 89. United Kingdom Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 90. United Kingdom Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 91. United Kingdom Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 92. Netherlands Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 93. Netherlands Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 94. Netherlands Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 95. Netherlands Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 96. Rest of Europe Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 97. Rest of Europe Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 98. Rest of Europe Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 99. Rest of Europe Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 100. MEA Diagnostic Reagents, by Country USD Million (2017-2022)
  • Table 101. MEA Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 102. MEA Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 103. MEA Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 104. MEA Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 105. Middle East Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 106. Middle East Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 107. Middle East Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 108. Middle East Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 109. Africa Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 110. Africa Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 111. Africa Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 112. Africa Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 113. North America Diagnostic Reagents, by Country USD Million (2017-2022)
  • Table 114. North America Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 115. North America Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 116. North America Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 117. North America Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 118. United States Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 119. United States Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 120. United States Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 121. United States Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 122. Canada Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 123. Canada Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 124. Canada Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 125. Canada Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 126. Mexico Diagnostic Reagents, by Type USD Million (2017-2022)
  • Table 127. Mexico Diagnostic Reagents, by Application USD Million (2017-2022)
  • Table 128. Mexico Diagnostic Reagents, by Technology USD Million (2017-2022)
  • Table 129. Mexico Diagnostic Reagents, by End-Users USD Million (2017-2022)
  • Table 130. Diagnostic Reagents Sales: by Type(K Units)
  • Table 131. Diagnostic Reagents Sales Reagents & Kits , by Region K Units (2017-2022)
  • Table 132. Diagnostic Reagents Sales Instruments , by Region K Units (2017-2022)
  • Table 133. Diagnostic Reagents Sales Others , by Region K Units (2017-2022)
  • Table 134. Diagnostic Reagents Sales: by Application(K Units)
  • Table 135. Diagnostic Reagents Sales Infectious Diseases [HIV, HAIs, HPV, TB] , by Region K Units (2017-2022)
  • Table 136. Diagnostic Reagents Sales Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer] , by Region K Units (2017-2022)
  • Table 137. Diagnostic Reagents Sales Genetic Tests , by Region K Units (2017-2022)
  • Table 138. Diagnostic Reagents Sales Other , by Region K Units (2017-2022)
  • Table 139. Diagnostic Reagents Sales: by Technology(K Units)
  • Table 140. Diagnostic Reagents Sales Polymerase Chain Reaction (PCR) , by Region K Units (2017-2022)
  • Table 141. Diagnostic Reagents Sales Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region K Units (2017-2022)
  • Table 142. Diagnostic Reagents Sales DNA Sequencing & Next-Generation Sequencing (NGS) , by Region K Units (2017-2022)
  • Table 143. Diagnostic Reagents Sales DNA Microarray , by Region K Units (2017-2022)
  • Table 144. Diagnostic Reagents Sales Others , by Region K Units (2017-2022)
  • Table 145. Diagnostic Reagents Sales: by End-Users(K Units)
  • Table 146. Diagnostic Reagents Sales Hospitals & Clinics , by Region K Units (2017-2022)
  • Table 147. Diagnostic Reagents Sales Research Laboratories , by Region K Units (2017-2022)
  • Table 148. Diagnostic Reagents Sales Academic Laboratories , by Region K Units (2017-2022)
  • Table 149. Diagnostic Reagents Sales Others , by Region K Units (2017-2022)
  • Table 150. South America Diagnostic Reagents Sales, by Country K Units (2017-2022)
  • Table 151. South America Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 152. South America Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 153. South America Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 154. South America Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 155. Brazil Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 156. Brazil Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 157. Brazil Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 158. Brazil Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 159. Argentina Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 160. Argentina Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 161. Argentina Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 162. Argentina Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 163. Rest of South America Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 164. Rest of South America Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 165. Rest of South America Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 166. Rest of South America Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 167. Asia Pacific Diagnostic Reagents Sales, by Country K Units (2017-2022)
  • Table 168. Asia Pacific Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 169. Asia Pacific Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 170. Asia Pacific Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 171. Asia Pacific Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 172. China Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 173. China Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 174. China Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 175. China Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 176. Japan Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 177. Japan Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 178. Japan Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 179. Japan Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 180. India Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 181. India Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 182. India Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 183. India Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 184. South Korea Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 185. South Korea Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 186. South Korea Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 187. South Korea Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 188. Taiwan Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 189. Taiwan Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 190. Taiwan Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 191. Taiwan Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 192. Australia Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 193. Australia Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 194. Australia Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 195. Australia Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 196. Rest of Asia-Pacific Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 197. Rest of Asia-Pacific Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 198. Rest of Asia-Pacific Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 199. Rest of Asia-Pacific Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 200. Europe Diagnostic Reagents Sales, by Country K Units (2017-2022)
  • Table 201. Europe Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 202. Europe Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 203. Europe Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 204. Europe Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 205. Germany Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 206. Germany Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 207. Germany Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 208. Germany Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 209. France Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 210. France Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 211. France Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 212. France Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 213. Italy Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 214. Italy Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 215. Italy Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 216. Italy Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 217. United Kingdom Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 218. United Kingdom Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 219. United Kingdom Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 220. United Kingdom Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 221. Netherlands Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 222. Netherlands Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 223. Netherlands Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 224. Netherlands Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 225. Rest of Europe Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 226. Rest of Europe Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 227. Rest of Europe Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 228. Rest of Europe Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 229. MEA Diagnostic Reagents Sales, by Country K Units (2017-2022)
  • Table 230. MEA Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 231. MEA Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 232. MEA Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 233. MEA Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 234. Middle East Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 235. Middle East Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 236. Middle East Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 237. Middle East Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 238. Africa Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 239. Africa Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 240. Africa Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 241. Africa Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 242. North America Diagnostic Reagents Sales, by Country K Units (2017-2022)
  • Table 243. North America Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 244. North America Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 245. North America Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 246. North America Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 247. United States Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 248. United States Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 249. United States Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 250. United States Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 251. Canada Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 252. Canada Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 253. Canada Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 254. Canada Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 255. Mexico Diagnostic Reagents Sales, by Type K Units (2017-2022)
  • Table 256. Mexico Diagnostic Reagents Sales, by Application K Units (2017-2022)
  • Table 257. Mexico Diagnostic Reagents Sales, by Technology K Units (2017-2022)
  • Table 258. Mexico Diagnostic Reagents Sales, by End-Users K Units (2017-2022)
  • Table 259. Diagnostic Reagents: by Type(USD/Units)
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Diagnostic Reagents: by Type(USD Million)
  • Table 274. Diagnostic Reagents Reagents & Kits , by Region USD Million (2023-2028)
  • Table 275. Diagnostic Reagents Instruments , by Region USD Million (2023-2028)
  • Table 276. Diagnostic Reagents Others , by Region USD Million (2023-2028)
  • Table 277. Diagnostic Reagents: by Application(USD Million)
  • Table 278. Diagnostic Reagents Infectious Diseases [HIV, HAIs, HPV, TB] , by Region USD Million (2023-2028)
  • Table 279. Diagnostic Reagents Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer] , by Region USD Million (2023-2028)
  • Table 280. Diagnostic Reagents Genetic Tests , by Region USD Million (2023-2028)
  • Table 281. Diagnostic Reagents Other , by Region USD Million (2023-2028)
  • Table 282. Diagnostic Reagents: by Technology(USD Million)
  • Table 283. Diagnostic Reagents Polymerase Chain Reaction (PCR) , by Region USD Million (2023-2028)
  • Table 284. Diagnostic Reagents Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region USD Million (2023-2028)
  • Table 285. Diagnostic Reagents DNA Sequencing & Next-Generation Sequencing (NGS) , by Region USD Million (2023-2028)
  • Table 286. Diagnostic Reagents DNA Microarray , by Region USD Million (2023-2028)
  • Table 287. Diagnostic Reagents Others , by Region USD Million (2023-2028)
  • Table 288. Diagnostic Reagents: by End-Users(USD Million)
  • Table 289. Diagnostic Reagents Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 290. Diagnostic Reagents Research Laboratories , by Region USD Million (2023-2028)
  • Table 291. Diagnostic Reagents Academic Laboratories , by Region USD Million (2023-2028)
  • Table 292. Diagnostic Reagents Others , by Region USD Million (2023-2028)
  • Table 293. South America Diagnostic Reagents, by Country USD Million (2023-2028)
  • Table 294. South America Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 295. South America Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 296. South America Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 297. South America Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 298. Brazil Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 299. Brazil Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 300. Brazil Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 301. Brazil Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 302. Argentina Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 303. Argentina Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 304. Argentina Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 305. Argentina Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 306. Rest of South America Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 307. Rest of South America Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 308. Rest of South America Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 309. Rest of South America Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 310. Asia Pacific Diagnostic Reagents, by Country USD Million (2023-2028)
  • Table 311. Asia Pacific Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 312. Asia Pacific Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 313. Asia Pacific Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 314. Asia Pacific Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 315. China Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 316. China Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 317. China Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 318. China Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 319. Japan Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 320. Japan Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 321. Japan Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 322. Japan Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 323. India Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 324. India Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 325. India Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 326. India Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 327. South Korea Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 328. South Korea Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 329. South Korea Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 330. South Korea Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 331. Taiwan Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 332. Taiwan Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 333. Taiwan Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 334. Taiwan Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 335. Australia Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 336. Australia Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 337. Australia Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 338. Australia Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 339. Rest of Asia-Pacific Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 340. Rest of Asia-Pacific Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 341. Rest of Asia-Pacific Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 342. Rest of Asia-Pacific Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 343. Europe Diagnostic Reagents, by Country USD Million (2023-2028)
  • Table 344. Europe Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 345. Europe Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 346. Europe Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 347. Europe Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 348. Germany Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 349. Germany Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 350. Germany Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 351. Germany Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 352. France Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 353. France Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 354. France Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 355. France Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 356. Italy Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 357. Italy Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 358. Italy Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 359. Italy Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 360. United Kingdom Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 361. United Kingdom Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 362. United Kingdom Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 363. United Kingdom Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 364. Netherlands Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 365. Netherlands Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 366. Netherlands Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 367. Netherlands Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 368. Rest of Europe Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 369. Rest of Europe Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 370. Rest of Europe Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 371. Rest of Europe Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 372. MEA Diagnostic Reagents, by Country USD Million (2023-2028)
  • Table 373. MEA Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 374. MEA Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 375. MEA Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 376. MEA Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 377. Middle East Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 378. Middle East Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 379. Middle East Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 380. Middle East Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 381. Africa Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 382. Africa Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 383. Africa Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 384. Africa Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 385. North America Diagnostic Reagents, by Country USD Million (2023-2028)
  • Table 386. North America Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 387. North America Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 388. North America Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 389. North America Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 390. United States Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 391. United States Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 392. United States Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 393. United States Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 394. Canada Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 395. Canada Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 396. Canada Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 397. Canada Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 398. Mexico Diagnostic Reagents, by Type USD Million (2023-2028)
  • Table 399. Mexico Diagnostic Reagents, by Application USD Million (2023-2028)
  • Table 400. Mexico Diagnostic Reagents, by Technology USD Million (2023-2028)
  • Table 401. Mexico Diagnostic Reagents, by End-Users USD Million (2023-2028)
  • Table 402. Diagnostic Reagents Sales: by Type(K Units)
  • Table 403. Diagnostic Reagents Sales Reagents & Kits , by Region K Units (2023-2028)
  • Table 404. Diagnostic Reagents Sales Instruments , by Region K Units (2023-2028)
  • Table 405. Diagnostic Reagents Sales Others , by Region K Units (2023-2028)
  • Table 406. Diagnostic Reagents Sales: by Application(K Units)
  • Table 407. Diagnostic Reagents Sales Infectious Diseases [HIV, HAIs, HPV, TB] , by Region K Units (2023-2028)
  • Table 408. Diagnostic Reagents Sales Oncology [Breast Cancer, Lung Cancer, Colorectal Cancer] , by Region K Units (2023-2028)
  • Table 409. Diagnostic Reagents Sales Genetic Tests , by Region K Units (2023-2028)
  • Table 410. Diagnostic Reagents Sales Other , by Region K Units (2023-2028)
  • Table 411. Diagnostic Reagents Sales: by Technology(K Units)
  • Table 412. Diagnostic Reagents Sales Polymerase Chain Reaction (PCR) , by Region K Units (2023-2028)
  • Table 413. Diagnostic Reagents Sales Isothermal Nucleic Acid Amplification Technology (INAAT) , by Region K Units (2023-2028)
  • Table 414. Diagnostic Reagents Sales DNA Sequencing & Next-Generation Sequencing (NGS) , by Region K Units (2023-2028)
  • Table 415. Diagnostic Reagents Sales DNA Microarray , by Region K Units (2023-2028)
  • Table 416. Diagnostic Reagents Sales Others , by Region K Units (2023-2028)
  • Table 417. Diagnostic Reagents Sales: by End-Users(K Units)
  • Table 418. Diagnostic Reagents Sales Hospitals & Clinics , by Region K Units (2023-2028)
  • Table 419. Diagnostic Reagents Sales Research Laboratories , by Region K Units (2023-2028)
  • Table 420. Diagnostic Reagents Sales Academic Laboratories , by Region K Units (2023-2028)
  • Table 421. Diagnostic Reagents Sales Others , by Region K Units (2023-2028)
  • Table 422. South America Diagnostic Reagents Sales, by Country K Units (2023-2028)
  • Table 423. South America Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 424. South America Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 425. South America Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 426. South America Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 427. Brazil Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 428. Brazil Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 429. Brazil Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 430. Brazil Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 431. Argentina Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 432. Argentina Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 433. Argentina Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 434. Argentina Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 435. Rest of South America Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 436. Rest of South America Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 437. Rest of South America Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 438. Rest of South America Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 439. Asia Pacific Diagnostic Reagents Sales, by Country K Units (2023-2028)
  • Table 440. Asia Pacific Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 441. Asia Pacific Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 442. Asia Pacific Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 443. Asia Pacific Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 444. China Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 445. China Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 446. China Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 447. China Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 448. Japan Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 449. Japan Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 450. Japan Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 451. Japan Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 452. India Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 453. India Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 454. India Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 455. India Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 456. South Korea Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 457. South Korea Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 458. South Korea Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 459. South Korea Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 460. Taiwan Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 461. Taiwan Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 462. Taiwan Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 463. Taiwan Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 464. Australia Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 465. Australia Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 466. Australia Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 467. Australia Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 468. Rest of Asia-Pacific Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 469. Rest of Asia-Pacific Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 470. Rest of Asia-Pacific Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 471. Rest of Asia-Pacific Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 472. Europe Diagnostic Reagents Sales, by Country K Units (2023-2028)
  • Table 473. Europe Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 474. Europe Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 475. Europe Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 476. Europe Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 477. Germany Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 478. Germany Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 479. Germany Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 480. Germany Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 481. France Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 482. France Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 483. France Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 484. France Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 485. Italy Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 486. Italy Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 487. Italy Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 488. Italy Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 489. United Kingdom Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 490. United Kingdom Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 491. United Kingdom Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 492. United Kingdom Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 493. Netherlands Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 494. Netherlands Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 495. Netherlands Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 496. Netherlands Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 497. Rest of Europe Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 498. Rest of Europe Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 499. Rest of Europe Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 500. Rest of Europe Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 501. MEA Diagnostic Reagents Sales, by Country K Units (2023-2028)
  • Table 502. MEA Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 503. MEA Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 504. MEA Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 505. MEA Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 506. Middle East Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 507. Middle East Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 508. Middle East Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 509. Middle East Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 510. Africa Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 511. Africa Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 512. Africa Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 513. Africa Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 514. North America Diagnostic Reagents Sales, by Country K Units (2023-2028)
  • Table 515. North America Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 516. North America Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 517. North America Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 518. North America Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 519. United States Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 520. United States Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 521. United States Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 522. United States Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 523. Canada Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 524. Canada Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 525. Canada Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 526. Canada Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 527. Mexico Diagnostic Reagents Sales, by Type K Units (2023-2028)
  • Table 528. Mexico Diagnostic Reagents Sales, by Application K Units (2023-2028)
  • Table 529. Mexico Diagnostic Reagents Sales, by Technology K Units (2023-2028)
  • Table 530. Mexico Diagnostic Reagents Sales, by End-Users K Units (2023-2028)
  • Table 531. Diagnostic Reagents: by Type(USD/Units)
  • Table 532. Research Programs/Design for This Report
  • Table 533. Key Data Information from Secondary Sources
  • Table 534. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostic Reagents: by Type USD Million (2017-2022)
  • Figure 5. Global Diagnostic Reagents: by Application USD Million (2017-2022)
  • Figure 6. Global Diagnostic Reagents: by Technology USD Million (2017-2022)
  • Figure 7. Global Diagnostic Reagents: by End-Users USD Million (2017-2022)
  • Figure 8. South America Diagnostic Reagents Share (%), by Country
  • Figure 9. Asia Pacific Diagnostic Reagents Share (%), by Country
  • Figure 10. Europe Diagnostic Reagents Share (%), by Country
  • Figure 11. MEA Diagnostic Reagents Share (%), by Country
  • Figure 12. North America Diagnostic Reagents Share (%), by Country
  • Figure 13. Global Diagnostic Reagents: by Type K Units (2017-2022)
  • Figure 14. Global Diagnostic Reagents: by Application K Units (2017-2022)
  • Figure 15. Global Diagnostic Reagents: by Technology K Units (2017-2022)
  • Figure 16. Global Diagnostic Reagents: by End-Users K Units (2017-2022)
  • Figure 17. South America Diagnostic Reagents Share (%), by Country
  • Figure 18. Asia Pacific Diagnostic Reagents Share (%), by Country
  • Figure 19. Europe Diagnostic Reagents Share (%), by Country
  • Figure 20. MEA Diagnostic Reagents Share (%), by Country
  • Figure 21. North America Diagnostic Reagents Share (%), by Country
  • Figure 22. Global Diagnostic Reagents: by Type USD/Units (2017-2022)
  • Figure 23. Global Diagnostic Reagents share by Players 2022 (%)
  • Figure 24. Global Diagnostic Reagents share by Players (Top 3) 2022(%)
  • Figure 25. Global Diagnostic Reagents share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Lifecycle Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Lifecycle Biotechnologies (United States) Revenue: by Geography 2022
  • Figure 29. Pointe Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pointe Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 33. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. Agilent Technologies (United States) Revenue: by Geography 2022
  • Figure 35. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Becton, Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 37. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 39. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 40. Hologic (United States) Revenue: by Geography 2022
  • Figure 41. Illumina (United States) Revenue, Net Income and Gross profit
  • Figure 42. Illumina (United States) Revenue: by Geography 2022
  • Figure 43. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Qiagen (Germany) Revenue: by Geography 2022
  • Figure 45. Roche Diagnostics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 46. Roche Diagnostics (Switzerland) Revenue: by Geography 2022
  • Figure 47. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Siemens AG (Germany) Revenue: by Geography 2022
  • Figure 49. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 50. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 51. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 52. BioMerieux (France) Revenue: by Geography 2022
  • Figure 53. Global Diagnostic Reagents: by Type USD Million (2023-2028)
  • Figure 54. Global Diagnostic Reagents: by Application USD Million (2023-2028)
  • Figure 55. Global Diagnostic Reagents: by Technology USD Million (2023-2028)
  • Figure 56. Global Diagnostic Reagents: by End-Users USD Million (2023-2028)
  • Figure 57. South America Diagnostic Reagents Share (%), by Country
  • Figure 58. Asia Pacific Diagnostic Reagents Share (%), by Country
  • Figure 59. Europe Diagnostic Reagents Share (%), by Country
  • Figure 60. MEA Diagnostic Reagents Share (%), by Country
  • Figure 61. North America Diagnostic Reagents Share (%), by Country
  • Figure 62. Global Diagnostic Reagents: by Type K Units (2023-2028)
  • Figure 63. Global Diagnostic Reagents: by Application K Units (2023-2028)
  • Figure 64. Global Diagnostic Reagents: by Technology K Units (2023-2028)
  • Figure 65. Global Diagnostic Reagents: by End-Users K Units (2023-2028)
  • Figure 66. South America Diagnostic Reagents Share (%), by Country
  • Figure 67. Asia Pacific Diagnostic Reagents Share (%), by Country
  • Figure 68. Europe Diagnostic Reagents Share (%), by Country
  • Figure 69. MEA Diagnostic Reagents Share (%), by Country
  • Figure 70. North America Diagnostic Reagents Share (%), by Country
  • Figure 71. Global Diagnostic Reagents: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Lifecycle Biotechnologies (United States)
  • Pointe Scientific, Inc. (United States)
  • Abbott Laboratories (United States)
  • Agilent Technologies (United States)
  • Becton, Dickinson and Company (United States)
  • Danaher Corporation (United States)
  • Hologic (United States)
  • Illumina (United States)
  • Qiagen (Germany)
  • Roche Diagnostics (Switzerland)
  • Siemens AG (Germany)
  • Thermo Fisher Scientific (United States)
  • BioMerieux (France)
Additional players considered in the study are as follows:
Diasorin (Italy) , Grifols (Spain)
Select User Access Type

Key Highlights of Report


Dec 2023 204 Pages 62 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Diagnostic Reagents Quantitative research analysis
Global (United States, European Union and China) Diagnostic Reagents Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Lifecycle Biotechnologies (United States), Pointe Scientific, Inc. (United States), Abbott Laboratories (United States), Agilent Technologies (United States), Becton, Dickinson and Company (United States), Danaher Corporation (United States), Hologic (United States), Illumina (United States), Qiagen (Germany), Roche Diagnostics (Switzerland), Siemens AG (Germany), Thermo Fisher Scientific (United States) and BioMerieux (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advancements in Molecular Techniques" is seen as one of major influencing trends for Diagnostic Reagents Market during projected period 2022-2028.
The Diagnostic Reagents market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global (United States, European Union and China) Diagnostic Reagents Report?

Have a Query? Click Here

Other Related Reports

Medical Adhesives Therapeutics Comprehensive Study by Type (Natural Resins, Synthetic Resins (Acrylic, Silicone, Polyurethanes)), Application (Dental, External Medical, Internal Medical, Medical Devi...
$ 3500
Genomic Biomarker Comprehensive Study by Type (Predictive Biomarkers, Prognostic Biomarkers, Others), Application (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Others), ...
$ 3800
Artificial Limbs Comprehensive Study by Type (Upper Artificial Limbs, Lower Artificial Limbs), Technology (Cosmetic Prosthetics, Cable Operated/ Body Powered, Electrically powered/ Myoelectric, Other...
$ 3450
Breast Massager Comprehensive Study by Type (Non-Electric Massager, Electric Massager), Application (Facilitates Breastfeeding., Helps Detect Breast Cancer., Relieves Tension., Improves Lactation Exp...
$ 3650
Medical Box Comprehensive Study by Type (Plastic, Metal, Others), Application (Home Use, Hospitals, Outdoor, Sports, Military, Others), Distribution Channel (Online, Offline) Players and Region - Glo...
$ 3500
Stationary Bicycle Comprehensive Study by Type (Upright Stationary Bicycle, Recumbent Stationary Bikes, Dual-action Stationary Bikes, Others), Application (Residential, Schools, Hospitals, Others), D...
$ 3450